137 related articles for article (PubMed ID: 5558834)
1. The effects of prostaglandins E 2 and F 2 alpha administered by different routes on uterine activity and the cardiovascular system in pregnant and non-pregnant women.
Karim SM; Hillier K; Somers K; Trussell RR
J Obstet Gynaecol Br Commonw; 1971 Feb; 78(2):172-9. PubMed ID: 5558834
[No Abstract] [Full Text] [Related]
2. Efficacy and safety of prostaglandin f-2-alpha as an abortifacient.
Kajanoja P; Widholm O
Ann Chir Gynaecol Fenn; 1974; 63(1):28-34. PubMed ID: 4832153
[No Abstract] [Full Text] [Related]
3. [Effects of E 2 and F 2 prostaglandins on uterine contractibility].
Noriega-Gurra L; Arévalo N; Guerrero C; Ortega E; Aznar-Ramos R
Arch Invest Med (Mex); 1972; 3():Suppl 1:201-12. PubMed ID: 4662650
[No Abstract] [Full Text] [Related]
4. Prostaglandins and reproduction in the rhesus monkey.
Kirton K; Duncan G; Oesterling T; Forbes A
Ann N Y Acad Sci; 1971 Apr; 180():445-55. PubMed ID: 4999663
[No Abstract] [Full Text] [Related]
5. Inhibition of prostaglandin induced uterine activity in the second trimester of pregnancy by beta-mimetic adrenergic agents.
Lindmark G; Melander S; Nilsson BA; Zador G
Prostaglandins; 1973 Apr; 3(4):481-9. PubMed ID: 4147100
[TBL] [Abstract][Full Text] [Related]
6. Absorption of prostaglandin E2 and uterine sensitivity of the non-pregnant and pregnant monkey in vivo.
Oshima K; Matsumoto K
Prostaglandins; 1973 Apr; 3(4):447-55. PubMed ID: 4199674
[No Abstract] [Full Text] [Related]
7. Cardiovascular and respiratory responses to intravenous infusion of prostaglandin F 2 in the pregnant woman.
Fishburne JI; Brenner WE; Braaksma JT; Staurovsky LG; Mueller RA; Hoffer JL; Hendricks CH
Am J Obstet Gynecol; 1972 Nov; 114(6):765-72. PubMed ID: 4573180
[No Abstract] [Full Text] [Related]
8. Cardiovascular and other effects of prostaglandins E 2 and F 2 in man.
Karim SM; Somers K; Hillier K
Cardiovasc Res; 1971 Jul; 5(3):255-9. PubMed ID: 5558723
[No Abstract] [Full Text] [Related]
9. In vivo inhibition of the human non-pregnant uterus by prostaglandin E2.
Toppozada M; Gaafar A; Shaala S
Prostaglandins; 1974 Dec; 8(5):401-10. PubMed ID: 4453624
[No Abstract] [Full Text] [Related]
10. Effect of prostaglandin E1 on the midpregnant human uterus. Intravenous, intramuscular, intra-amniotic, and vaginal administration.
Wiqvist N; Bygdeman M; Kwon SU; Mukherjee T; Roth-Brandel U
Am J Obstet Gynecol; 1968 Oct; 102(3):327-32. PubMed ID: 5675883
[TBL] [Abstract][Full Text] [Related]
11. Effect of PGE 2 and PGF 2 alpha on uterine contractility.
Hendriks C
Ann N Y Acad Sci; 1971 Apr; 180():528-30. PubMed ID: 5286108
[No Abstract] [Full Text] [Related]
12. Action of prostaglandin in the pregnant woman.
Karim S
Ann N Y Acad Sci; 1971 Apr; 180():483-98. PubMed ID: 4999664
[No Abstract] [Full Text] [Related]
13. The efficacy and acceptability of the "prostaglandin impact" in inducing complete abortion during the second week after the missed menstrual period.
Csapo AI; Mocsary P; Nagy T; Kaihola HL
Prostaglandins; 1973 Feb; 3(2):125-39. PubMed ID: 4729565
[TBL] [Abstract][Full Text] [Related]
14. Aerosol administration of prostaglandins E 1 and E 2 and isoproterenol: studies on the cardiovascular system.
Wendt RL; Baum T
Eur J Pharmacol; 1972 Jan; 17(1):141-51. PubMed ID: 5016573
[No Abstract] [Full Text] [Related]
15. Response of the midpregnant human uterus to systemic administration of 15(S)-15-methyl-prostaglandin F2alpha.
Toppozada M; Béguin F; Bygdeman M; Wiqvist N
Prostaglandins; 1972 Oct; 2(4):239-49. PubMed ID: 4666626
[TBL] [Abstract][Full Text] [Related]
16. The effect of the prostaglandin F compounds on the contractility of the pregnant human uterus.
Bygdeman M; Kwon SU; Mukherjee T; Roth-Brandel U; Wiqvist N
Am J Obstet Gynecol; 1970 Feb; 106(4):567-72. PubMed ID: 5412850
[TBL] [Abstract][Full Text] [Related]
17. [Effects of prostaglandins E 2 and F 2 on uterine contractility].
Noriega-Guerra L; Arévalo N; Guerrero C; Ortega E; Aznar-Ramos R
Arch Invest Med (Mex); 1972; 3():Suppl 1:201-12. PubMed ID: 4657738
[No Abstract] [Full Text] [Related]
18. The induction of therapeutic abortion using intravenous prostaglandin F 2 alpha.
Anderson GG; Hobbins JC; Speroff L; Caldwell BV
Contraception; 1972 Apr; 5(4):303-11. PubMed ID: 4650655
[No Abstract] [Full Text] [Related]
19. The prospects of PGs in postconceptional therapy.
Csapo AI
Prostaglandins; 1973 Mar; 3(3):245-89. PubMed ID: 4580931
[TBL] [Abstract][Full Text] [Related]
20. Induction of therapeutic abortion using either extra-amniotic prostaglandin F-2-alpha or hypertonic saline followed by oxytocin.
Lange AP; Secher NJ; Pedersen GT
Prostaglandins; 1974 Apr; 6(2):149-57. PubMed ID: 4847514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
